French biotech company Transgene has acquired rights to commercialise a novel cancer vaccine that is being tested against multiple types …
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine

